Skip to main content
Top
Published in: Infection 3/2023

Open Access 25-02-2023 | Antibiotic | Review

Choosing Wisely internationally – helpful recommendations for antimicrobial stewardship!

Authors: Norma Jung, Lukas Tometten, Rika Draenert

Published in: Infection | Issue 3/2023

Login to get access

Abstract

Purpose

Antimicrobial resistance poses a major threat to human health globally and antibiotic overuse is a main driver of resistance. Antimicrobial stewardship (AMS) was developed to improve the rationale use of antibiotics. The Choosing Wisely campaign was initiated to ameliorate medical practice through avoidance of unnecessary diagnostic and therapeutic procedures. Our objective was to give an overview on the Choosing Wisely recommendations related to AMS practices from a selection of different countries in order to define future needs.

Methods

We evaluated the seven countries already analyzed for Choosing Wisely recommendations related to topics of infectious medicine before. Finally, we included five of the former countries (Australia/New Zealand, Canada, Italy, Switzerland, and USA) and Germany with easily accessible recommendations and selected those related to six categories of AMS as following: diagnostics, indication, choice of antiinfective drugs, dosing, application and duration of therapy.

Results

In total, 213 recommendations could be extracted related to AMS for the six countries and were matched to the chosen categories. Interestingly, no recommendations were found for the category “dosing.” Topics related to indication and diagnostics were most frequently found with 85 and 78 recommendations, respectively. Perioperative prophylaxis was a frequently addressed issue – both related to application, indication and duration. Avoiding antibiotic treatment of asymptomatic bacteriuria and upper respiratory tract infections were central topics of all countries.

Conclusion

AMS is an important strategy to fight increasing resistance and is frequently addressed by Choosing Wisely recommendations of different countries. Similar issues are considered important in the selected countries.
Literature
1.
go back to reference Antimicrobial RC. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55.CrossRef Antimicrobial RC. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55.CrossRef
2.
go back to reference Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13.CrossRefPubMedPubMedCentral Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13.CrossRefPubMedPubMedCentral
3.
go back to reference Cassini A, Hogberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19:56–66.CrossRefPubMedPubMedCentral Cassini A, Hogberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19:56–66.CrossRefPubMedPubMedCentral
5.
go back to reference Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al. Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America. Clin Infect Dis. 2016;62:e51–77.CrossRefPubMedPubMedCentral Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, et al. Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America. Clin Infect Dis. 2016;62:e51–77.CrossRefPubMedPubMedCentral
7.
go back to reference Morden NE, Colla CH, Sequist TD, Rosenthal MB. Choosing wisely–the politics and economics of labeling low-value services. N Engl J Med. 2014;370:589–92.CrossRefPubMedPubMedCentral Morden NE, Colla CH, Sequist TD, Rosenthal MB. Choosing wisely–the politics and economics of labeling low-value services. N Engl J Med. 2014;370:589–92.CrossRefPubMedPubMedCentral
8.
go back to reference Wolfson D, Santa J, Slass L. Engaging physicians and consumers in conversations about treatment overuse and waste: a short history of the choosing wisely campaign. Acad Med. 2014;89:990–5.CrossRefPubMed Wolfson D, Santa J, Slass L. Engaging physicians and consumers in conversations about treatment overuse and waste: a short history of the choosing wisely campaign. Acad Med. 2014;89:990–5.CrossRefPubMed
10.
go back to reference Jung N, Lehmann C, Fatkenheuer G. The, “choosing wisely”: initiative in infectious diseases. Infection. 2016;44:283–90.CrossRefPubMed Jung N, Lehmann C, Fatkenheuer G. The, “choosing wisely”: initiative in infectious diseases. Infection. 2016;44:283–90.CrossRefPubMed
11.
13.
go back to reference Branch-Elliman W, O’Brien W, Strymish J, Itani K, Wyatt C, Gupta K. Association of duration and type of surgical prophylaxis with antimicrobial-associated adverse events. JAMA Surg. 2019;154:590–8.CrossRefPubMedPubMedCentral Branch-Elliman W, O’Brien W, Strymish J, Itani K, Wyatt C, Gupta K. Association of duration and type of surgical prophylaxis with antimicrobial-associated adverse events. JAMA Surg. 2019;154:590–8.CrossRefPubMedPubMedCentral
14.
go back to reference de Jonge SW, Boldingh QJJ, Solomkin JS, Dellinger EP, Egger M, Salanti G, et al. Effect of postoperative continuation of antibiotic prophylaxis on the incidence of surgical site infection: a systematic review and meta-analysis. Lancet Infect Dis. 2020;20:1182–92.CrossRefPubMed de Jonge SW, Boldingh QJJ, Solomkin JS, Dellinger EP, Egger M, Salanti G, et al. Effect of postoperative continuation of antibiotic prophylaxis on the incidence of surgical site infection: a systematic review and meta-analysis. Lancet Infect Dis. 2020;20:1182–92.CrossRefPubMed
15.
go back to reference Miranda D, Mermel LA, Dellinger EP. Perioperative antibiotic prophylaxis: surgeons as antimicrobial stewards. J Am Coll Surg. 2020;231:766–8.CrossRefPubMed Miranda D, Mermel LA, Dellinger EP. Perioperative antibiotic prophylaxis: surgeons as antimicrobial stewards. J Am Coll Surg. 2020;231:766–8.CrossRefPubMed
16.
go back to reference Mazuski JE. Perioperative antibiotic prophylaxis: can we do better? J Am Coll Surg. 2020;231:768–9.CrossRefPubMed Mazuski JE. Perioperative antibiotic prophylaxis: can we do better? J Am Coll Surg. 2020;231:768–9.CrossRefPubMed
17.
go back to reference Pouly E, Coppry M, Rogues AM, Dumartin C. Systematic review of factors promoting behaviour change toward antibiotic use in hospitals. Clin Microbiol Infect. 2022;28:911–9.CrossRefPubMed Pouly E, Coppry M, Rogues AM, Dumartin C. Systematic review of factors promoting behaviour change toward antibiotic use in hospitals. Clin Microbiol Infect. 2022;28:911–9.CrossRefPubMed
18.
go back to reference Charani E, de Barra E, Rawson TM, Gill D, Gilchrist M, Naylor NR, et al. Antibiotic prescribing in general medical and surgical specialties: a prospective cohort study. Antimicrob Resist Infect Control. 2019;8:151.CrossRefPubMedPubMedCentral Charani E, de Barra E, Rawson TM, Gill D, Gilchrist M, Naylor NR, et al. Antibiotic prescribing in general medical and surgical specialties: a prospective cohort study. Antimicrob Resist Infect Control. 2019;8:151.CrossRefPubMedPubMedCentral
19.
go back to reference Charani E, Ahmad R, Tarrant C, Birgand G, Leather A, Mendelson M, et al. Opportunities for system level improvement in antibiotic use across the surgical pathway. Int J Infect Dis. 2017;60:29–34.CrossRefPubMed Charani E, Ahmad R, Tarrant C, Birgand G, Leather A, Mendelson M, et al. Opportunities for system level improvement in antibiotic use across the surgical pathway. Int J Infect Dis. 2017;60:29–34.CrossRefPubMed
20.
go back to reference Charani E, Ahmad R, Rawson TM, Castro-Sanchez E, Tarrant C, Holmes AH. The differences in antibiotic decision-making between acute surgical and acute medical teams: an ethnographic study of culture and team dynamics. Clin Infect Dis. 2019;69:12–20.CrossRefPubMed Charani E, Ahmad R, Rawson TM, Castro-Sanchez E, Tarrant C, Holmes AH. The differences in antibiotic decision-making between acute surgical and acute medical teams: an ethnographic study of culture and team dynamics. Clin Infect Dis. 2019;69:12–20.CrossRefPubMed
22.
go back to reference Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, et al. Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. Clin Infect Dis. 2013;56:236–44.CrossRefPubMed Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, et al. Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. Clin Infect Dis. 2013;56:236–44.CrossRefPubMed
23.
go back to reference Abdul-Aziz MH, Dulhunty JM, Bellomo R, Lipman J, Roberts JA. Continuous beta-lactam infusion in critically ill patients: the clinical evidence. Ann Intensiv Care. 2012;2:37.CrossRef Abdul-Aziz MH, Dulhunty JM, Bellomo R, Lipman J, Roberts JA. Continuous beta-lactam infusion in critically ill patients: the clinical evidence. Ann Intensiv Care. 2012;2:37.CrossRef
24.
go back to reference Fathi A, Hennigs A, Addo MM. Less is more... in infectious diseases. Internist (Berl). 2021; 62(4): 373–8. Fathi A, Hennigs A, Addo MM. Less is more... in infectious diseases. Internist (Berl). 2021; 62(4): 373–8.
26.
go back to reference Cox JA, Vlieghe E, Mendelson M, Wertheim H, Ndegwa L, Villegas MV, et al. Antibiotic stewardship in low- and middle-income countries: the same but different? Clin Microbiol Infect. 2017;23:812–8.CrossRefPubMed Cox JA, Vlieghe E, Mendelson M, Wertheim H, Ndegwa L, Villegas MV, et al. Antibiotic stewardship in low- and middle-income countries: the same but different? Clin Microbiol Infect. 2017;23:812–8.CrossRefPubMed
Metadata
Title
Choosing Wisely internationally – helpful recommendations for antimicrobial stewardship!
Authors
Norma Jung
Lukas Tometten
Rika Draenert
Publication date
25-02-2023
Publisher
Springer Berlin Heidelberg
Keyword
Antibiotic
Published in
Infection / Issue 3/2023
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-023-02005-y

Other articles of this Issue 3/2023

Infection 3/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine